Peripheral ai-symbiont

Peripheral ai-symbiont inhibits Peripheral Vicious Cycle in humans.

“PAIS offers particular advantages for anti-aging strategies by enhancing organismal regulatory mechanisms and counteracting the Peripheral Vicious Cycle — a key upstream driver of aging”

Review

The Peripheral Imperative: Why Invasive Cortical BCI Is Unsuitable for Healthy Individuals and Long-Term Human-AI Symbiosis

Zenodo (CERN European Organization for Nuclear Research)·26 May 2026Preprint

Peripheral ai-symbiont improves neuroplasticity in humans.

“PAIS interrupts the peripheral-to-central loop at its origin, thereby preserving adaptive neuroplasticity in both terrestrial aging and microgravity conditions”

Reviewin terrestrial aging and microgravity conditions

The Peripheral Vicious Cycle Hypothesis: Peripheral Origin of Prefrontal Neuroplasticity Decline in Aging and Its Acceleration Under Low-Microgravity

Zenodo (CERN European Organization for Nuclear Research)·12 May 2026Preprint

Peripheral ai-symbiont decreases biological age.

“By neutralizing the root peripheral driver of inflammaging, the PAIS is expected to restore tissue homeostasis, enhance resilience, and significantly slow or partially reverse key aspects of biological aging”

Review

Peripheral AI-Symbiont (PAIS): Upstream Intervention in Aging via Localized Autonomous Micro/Nano-Robotic Network

Zenodo (CERN European Organization for Nuclear Research)·1 May 2026Preprint